Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/9235
Title: Antidiabetic Activity of Sedum dendroideum: Metabolic Enzymes as Putative Targets for the Bioactive Flavonoid Kaempferitrin
Authors: Silva, Daniel da
Casanova, Livia Marques
Marcondes, Mariah Celestino
Espindola Netto, Jair Machado
Paixão, Larissa Pereira
Melo, Giany Oliveira de
Zancan, Patrícia
Penna, Mauro Sola
Costa, Sonia Soares
Keywords: Diabetes Mellitus
Flavonoides
Quempferóis
Kaempferols
Fosfofrutoquinase-2
Phosphofructokinase-2
Fosfofructoquinasa-2
Flavonoids
Quempferoles
Issue Date: 2014
Publisher: International Union of Biochemistry and Molecular Biology Life
Citation: SILVA, Daniel da et al. Antidiabetic Activity of Sedum dendroideum: Metabolic Enzymes as Putative Targets for the Bioactive Flavonoid Kaempferitrin. International Union of Biochemistry and Molecular Biology Life, v. 66, n. 5, p. 361-370, may 2014.
Abstract: The aim of this study was to evaluate the antidiabetic potentialof a leaf extract and flavonoids fromSedum dendroideum(SD). Additionally, our goals were to establish a possible struc-ture/activity relationship between these flavonoids and toassess the most active flavonoid on the glycolytic enzyme 6-phosphofructo-1-kinase (PFK). SD juice (LJ), a flavonoid-richfraction (BF), and separately five flavonoids were evaluatedintraperitoneally for their acute hypoglycemic activity in normaland streptozotocin-induced diabetic mice. First, the majorflavonoids kaempferol 3,7-dirhamnoside or kaempferitrin (1),kaempferol 3-glucoside-7-rhamnoside (2), and kaempferol 3-neohesperidoside-7-rhamnoside (3) were tested. Then, themonoglycosides kaempferol 7-rhamnoside (5) and kaempferol3-rhamnoside (6) were assayed to establish their structure/activ-ity relationship. The effect of 1 on PFK was evaluated in skeletalmuscle, liver, and adipose tissue from treated mice. LJ (400mg/kg), BF (40 mg/kg), and flavonoid 1 (4 mg/kg) reduced gly-cemia in diabetic mice (120 min) by 52, 53, and 61%, respec-tively. Flavonoids 2, 3, 5, and 6 were inactive or showed littleactivity, suggesting that the two rhamnosyl moieties in kaemp-feritrin are important requirements. Kaempferitrin enhanced thePFK activity chiefly in hepatic tissue, suggesting that it is ableto stimulate tissue glucose utilization. This result is confirmedtesting kaempferitrin on C2C12 cell line, where it enhanced glu-cose consumption, lactate production, and the key regulatoryglycolytic enzymes. The hypoglycemic activity of kaempferitrindepends on the presence of both rhamnosyl residues in the fla-vonoid structure when intraperitoneally administered. Our find-ings show for the first time that a flavonoid is capable ofstimulating PFK in a model of diabetes and that kaempferitrinstimulates glucose-metabolizing enzymes. This study contrib-utes to the knowledge of the mechanisms by which this flavo-noid exerts its hypoglycemic activity.
Description: p. 361-370.: il. p&b.
URI: http://sr-vmlxaph03:8080/jspui/handle/123456789/9235
ISSN: 1521-6551
Appears in Collections:Artigos de Periódicos da área de Farmácia



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.